Global Genomic Analysis of AlgU (σE)-Dependent Promoters (Sigmulon) in Pseudomonas aeruginosa and Implications for Inflammatory Processes in Cystic Fibrosis

ABSTRACT The conversion of Pseudomonas aeruginosa to the mucoid phenotype coincides with the establishment of chronic respiratory infections in cystic fibrosis (CF). A major pathway of conversion to mucoidy in clinical strains of P. aeruginosa is dependent upon activation of the alternative sigma factor AlgU (P. aeruginosa σE). Here we initiated studies of AlgU-dependent global expression patterns in P. aeruginosa in order to assess whether additional genes, other than those involved in the production of the mucoid exopolysaccharide alginate, are turned on during conversion to mucoidy. Using genomic information and the consensus AlgU promoter sequence, we identified 35 potential AlgU (σE) promoter sites on the P. aeruginosa chromosome. Each candidate promoter was individually tested by reverse transcription and mRNA 5′-end mapping using RNA isolated from algU+ and algU::Tcr mutant cells. A total of 10 new AlgU-dependent promoters were identified, and the corresponding mRNA start sites were mapped. Two of the 10 newly identified AlgU promoters were upstream of predicted lipoprotein genes. Since bacterial lipoproteins have been implicated as inducers of inflammatory pathways, we tested whether lipopeptides corresponding to the products of the newly identified AlgU-dependent lipoprotein genes, lptA and lptB, had proinflammatory activity. In human peripheral blood monocyte-derived macrophages the peptides caused production of interleukin-8, a proinflammatory chemokine typically present at excessively high levels in the CF lung. Our studies show how genomic information can be used to uncover on a global scale the genes controlled by a given σ factor (collectively termed here sigmulon) using conventional molecular tools. In addition, our data suggest the existence of a previously unknown connection between conversion to mucoidy and expression of lipoproteins with potential proinflammatory activity. This link may be of significance for infections and inflammatory processes in CF.

[1]  H. Mollenkopf,et al.  SlyA, a regulatory protein from Salmonella typhimurium, induces a haemolytic and pore-forming protein in Escherichia coli , 1995, Molecular and General Genetics MGG.

[2]  V. Deretic,et al.  Conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients. , 2001, Methods in enzymology.

[3]  V. Deretic,et al.  CFTR and pseudomonas infections in cystic fibrosis. , 2001, Frontiers in bioscience : a journal and virtual library.

[4]  K. Mathee,et al.  Proteome Analysis of the Effect of Mucoid Conversion on Global Protein Expression in Pseudomonas aeruginosa Strain PAO1 Shows Induction of the Disulfide Bond Isomerase, DsbA , 2000, Journal of bacteriology.

[5]  S. Lory,et al.  Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen , 2000, Nature.

[6]  V. Deretic,et al.  Dual regulation of mucoidy in Pseudomonas aeruginosa and sigma factor antagonism , 2000, Molecular microbiology.

[7]  V. Deretic,et al.  Membrane‐to‐cytosol redistribution of ECF sigma factor AlgU and conversion to mucoidy in Pseudomonas aeruginosa isolates from cystic fibrosis patients , 2000, Molecular microbiology.

[8]  M. Vasil,et al.  Genetics and regulation of two distinct haem-uptake systems, phu and has, in Pseudomonas aeruginosa. , 2000, Microbiology.

[9]  Fiona S. L. Brinkman,et al.  Influence of a Putative ECF Sigma Factor on Expression of the Major Outer Membrane Protein, OprF, in Pseudomonas aeruginosa and Pseudomonas fluorescens , 1999, Journal of bacteriology.

[10]  P. Godowski,et al.  Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. , 1999, Science.

[11]  B. Bloom,et al.  Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. , 1999, Science.

[12]  D. Missiakas,et al.  The extracytoplasmic function sigma factors: role and regulation , 1998, Molecular microbiology.

[13]  Roland Lange,et al.  Interplay between global regulators of Escherichia coli : effect of RpoS, Lrp and H‐NS on transcription of the gene osmC , 1998, Molecular microbiology.

[14]  M. Hanes,et al.  Microbial Pathogenesis in Cystic Fibrosis: Pulmonary Clearance of Mucoid Pseudomonas aeruginosa and Inflammation in a Mouse Model of Repeated Respiratory Challenge , 1998, Infection and Immunity.

[15]  V. Deretic,et al.  Pseudomonas aeruginosa in cystic fibrosis: role of mucC in the regulation of alginate production and stress sensitivity. , 1997, Microbiology.

[16]  V. Deretic,et al.  Mucoid Pseudomonas aeruginosa in cystic fibrosis: characterization of muc mutations in clinical isolates and analysis of clearance in a mouse model of respiratory infection , 1997, Infection and immunity.

[17]  T. Silhavy,et al.  The sigma(E) and the Cpx signal transduction systems control the synthesis of periplasmic protein-folding enzymes in Escherichia coli. , 1997, Genes & development.

[18]  V. Deretic,et al.  Microbial pathogenesis in cystic fibrosis: co‐ordinate regulation of heat‐shock response and conversion to mucoidy in Pseudomonas aeruginosa , 1997, Molecular microbiology.

[19]  V. Deretic,et al.  Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. , 1996, Microbiological reviews.

[20]  V. Deretic,et al.  Control of AlgU, a member of the sigma E-like family of stress sigma factors, by the negative regulators MucA and MucB and Pseudomonas aeruginosa conversion to mucoidy in cystic fibrosis , 1996, Journal of bacteriology.

[21]  Q. Gu,et al.  Multicopy suppressors of prc mutant Escherichia coli include two HtrA (DegP) protease homologs (HhoAB), DksA, and a truncated R1pA , 1996, Journal of bacteriology.

[22]  V. Deretic,et al.  Two distinct loci affecting conversion to mucoidy in Pseudomonas aeruginosa in cystic fibrosis encode homologs of the serine protease HtrA , 1996, Journal of bacteriology.

[23]  K. Young,et al.  Isolation and Amino Acid Sequence of a New 22-kDa FKBP-like Peptidyl-prolyl cis/trans-Isomerase of Escherichia coli SIMILARITY TO Mip-LIKE PROTEINS OF PATHOGENIC BACTERIA* , 1996 .

[24]  M. Konstan,et al.  Inflammatory cytokines in cystic fibrosis lungs. , 1995, American journal of respiratory and critical care medicine.

[25]  H. Sahm,et al.  Transaldolase B of Escherichia coli K-12: cloning of its gene, talB, and characterization of the enzyme from recombinant strains , 1995, Journal of bacteriology.

[26]  N. Hibler,et al.  Multiple promoters and induction by heat shock of the gene encoding the alternative sigma factor AlgU (sigma E) which controls mucoidy in cystic fibrosis isolates of Pseudomonas aeruginosa , 1995, Journal of bacteriology.

[27]  V. Deretic,et al.  Pseudomonas aeruginosa, mucoidy and the chronic infection phenotype in cystic fibrosis. , 1995, Trends in microbiology.

[28]  V. Deretic,et al.  Functional equivalence of Escherichia coli sigma E and Pseudomonas aeruginosa AlgU: E. coli rpoE restores mucoidy and reduces sensitivity to reactive oxygen intermediates in algU mutants of P. aeruginosa , 1995, Journal of bacteriology.

[29]  K. Makino,et al.  The rpoE gene of Escherichia coli, which encodes sigma E, is essential for bacterial growth at high temperature , 1995, Journal of bacteriology.

[30]  D. Riches,et al.  Early pulmonary inflammation in infants with cystic fibrosis. , 1995, American journal of respiratory and critical care medicine.

[31]  P. J. Byard,et al.  Effect of high-dose ibuprofen in patients with cystic fibrosis. , 1995, The New England journal of medicine.

[32]  K. Rudd,et al.  rpoE, the gene encoding the second heat‐shock sigma factor, sigma E, in Escherichia coli. , 1995, The EMBO journal.

[33]  D. Ohman,et al.  Mucoid-to-nonmucoid conversion in alginate-producing Pseudomonas aeruginosa often results from spontaneous mutations in algT, encoding a putative alternate sigma factor, and shows evidence for autoregulation , 1994, Journal of bacteriology.

[34]  D. Martin,et al.  Analysis of promoters controlled by the putative sigma factor AlgU regulating conversion to mucoidy in Pseudomonas aeruginosa: relationship to sigma E and stress response , 1994, Journal of bacteriology.

[35]  M. Winkler,et al.  An Escherichia coli K-12 tktA tktB mutant deficient in transketolase activity requires pyridoxine (vitamin B6) as well as the aromatic amino acids and vitamins for growth , 1994, Journal of bacteriology.

[36]  R. Crystal,et al.  Protease-antiprotease imbalance in the lungs of children with cystic fibrosis. , 1994, American journal of respiratory and critical care medicine.

[37]  D. Martin,et al.  Gene cluster controlling conversion to alginate-overproducing phenotype in Pseudomonas aeruginosa: functional analysis in a heterologous host and role in the instability of mucoidy , 1994, Journal of bacteriology.

[38]  D. Martin,et al.  Conversion of Pseudomonas aeruginosa to mucoidy in cystic fibrosis: environmental stress and regulation of bacterial virulence by alternative sigma factors , 1994, Journal of bacteriology.

[39]  S. Fitzsimmons.  The changing epidemiology of cystic fibrosis. , 1994, Current problems in pediatrics.

[40]  D. Martin,et al.  Differentiation of Pseudomonas aeruginosa into the alginate‐producing form: inactivation of mucB causes conversion to mucoidy , 1993, Molecular microbiology.

[41]  N. Høiby,et al.  Pathogenesis of cystic fibrosis , 1993, The Lancet.

[42]  P. Jorens,et al.  Interleukin-8: an important chemoattractant in sputum of patients with chronic inflammatory airway diseases. , 1993, The American journal of physiology.

[43]  A. Pugsley.  The complete general secretory pathway in gram-negative bacteria. , 1993, Microbiological reviews.

[44]  D. Martin,et al.  Characterization of a locus determining the mucoid status of Pseudomonas aeruginosa: AlgU shows sequence similarities with a Bacillus sigma factor , 1993, Journal of bacteriology.

[45]  D. Martin,et al.  Mechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[46]  S. Pedersen,et al.  Lung infection with alginate-producing, mucoid Pseudomonas aeruginosa in cystic fibrosis. , 1992, APMIS. Supplementum.

[47]  A. Kharazmi,et al.  Pseudomonas aeruginosa alginate in cystic fibrosis sputum and the inflammatory response , 1990, Infection and immunity.

[48]  J. Costerton,et al.  Human polymorphonuclear leukocyte response to Pseudomonas aeruginosa grown in biofilms , 1990, Infection and immunity.

[49]  C. Gross,et al.  Identification of the sigma E subunit of Escherichia coli RNA polymerase: a second alternate sigma factor involved in high-temperature gene expression. , 1989, Genes & development.

[50]  R. Dean,et al.  Scavenging by alginate of free radicals released by macrophages. , 1989, Free radical biology & medicine.

[51]  R. Helmke,et al.  Resistance of mucoid Pseudomonas aeruginosa to nonopsonic phagocytosis by alveolar macrophages in vitro , 1988, Infection and immunity.

[52]  C. Georgopoulos,et al.  Sequence analysis and regulation of the htrA gene of Escherichia coli: a sigma 32-independent mechanism of heat-inducible transcription. , 1988, Nucleic acids research.

[53]  M. Eshoo.  lac fusion analysis of the bet genes of Escherichia coli: regulation by osmolarity, temperature, oxygen, choline, and glycine betaine , 1988, Journal of bacteriology.

[54]  H. Stiver,et al.  Inhibition of polymorphonuclear leukocyte chemotaxis by the mucoid exopolysaccharide of Pseudomonas aeruginosa. , 1988, Clinical and investigative medicine. Medecine clinique et experimentale.

[55]  R. Hancock,et al.  Construction and characterization of Pseudomonas aeruginosa protein F-deficient mutants after in vitro and in vivo insertion mutagenesis of the cloned gene , 1988, Journal of bacteriology.

[56]  W. Bessler,et al.  Stimulation of human and murine adherent cells by bacterial lipoprotein and synthetic lipopeptide analogues. , 1988, Immunobiology.

[57]  D. Ohman,et al.  Cloning of genes from mucoid Pseudomonas aeruginosa which control spontaneous conversion to the alginate production phenotype , 1988, Journal of bacteriology.

[58]  H. Domdey,et al.  Sequence and transcriptional start site of the Pseudomonas aeruginosa outer membrane porin protein F gene , 1988, Journal of bacteriology.

[59]  R. Dean,et al.  Alginate inhibition of the uptake of Pseudomonas aeruginosa by macrophages. , 1988, Journal of general microbiology.

[60]  D. Learn,et al.  Hypochlorite scavenging by Pseudomonas aeruginosa alginate , 1987, Infection and immunity.

[61]  A. Chakrabarty,et al.  Pseudomonas aeruginosa infection in cystic fibrosis: nucleotide sequence and transcriptional regulation of the algD gene. , 1987, Nucleic acids research.

[62]  Weir Dm,et al.  Inhibition of bacterial binding to mouse macrophages by Pseudomonas alginate. , 1983 .

[63]  D. Weir,et al.  Inhibition of bacterial binding to mouse macrophages by Pseudomonas alginate. , 1983, Journal of clinical & laboratory immunology.

[64]  J. Fyfe,et al.  Alginate synthesis in mucoid Pseudomonas aeruginosa: a chromosomal locus involved in control. , 1980, Journal of general microbiology.

[65]  J. Gustafson,et al.  Cystic Fibrosis , 2009, Journal of the Iowa Medical Society.